ImmunoGen Inc of Waltham, Massachusetts has appointed Theresa Wingrove as vice president of regulatory affairs, reporting to the chief executive, Daniel Junius. Dr Wingrove was most recently vice president of regulatory and clinical affairs at Histogenics Corp and prior to that, senior director of regulatory and clinical affairs at MediSpectra Inc, both in the US. At ImmunoGen, she will direct regulatory submissions for the company and its partners. She holds a BS in biochemistry from Brown University and a doctorate in biochemical toxicology from the University of Rochester. ImmunoGen is a leader in antibody-drug conjugate technology.
Copyright 2010 Evernow Publishing Ltd